Drug intelligence / Profile preview

ginsenoside Rg2

Development stage
Unknown
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intraperitoneal (preclinical Studies)
01

Overview

Ginsenoside Rg2 is a naturally occurring saponin compound classified as a ginsenoside and is found in Panax species such as Panax ginseng. It is a dammarane-type tetracyclic triterpenoid glycoside with multiple hydroxy substitutions and sugar moieties. Ginsenoside Rg2 exhibits diverse pharmacological activities including cardioprotective effects (notably against drug-induced cardiotoxicity), neuroprotective actions (protection of nerve cells and potential benefit in cognitive impairment), anti-inflammatory properties (suppression of pro-inflammatory signaling pathways), anticoagulant activity, and anti-diabetic effects. Mechanistically, it modulates several cellular signaling pathways such as NF-κB inhibition; regulation of MAPK/ERK pathway; PI3K/Akt/mTOR pathway modulation; AMPK activation leading to reduced hepatic glucose production; inhibition of apoptosis via caspase regulation; suppression of cell adhesion molecules like VCAM-1 and ICAM-1 under inflammatory conditions; regulation of 5-HT3A receptors and nicotinic acetylcholine receptor-mediated ion fluxes. Its therapeutic potential has been explored for type 2 diabetes mellitus, vascular dementia or other ischemic insults to the nervous system, myocardial injury/apoptosis prevention especially in the context of trastuzumab-induced cardiotoxicity in preclinical models[1][4][5][6].

Other names
Chikusetsusaponin Iginsenoside-Rg2ginsenoside-Rg-2ginsenoside-Rg 2(3beta,6alpha,12beta,20R)-isomer
02

Targets

NF-κBMEKGSK3 (Glycogen synthase kinase 3 beta)AMPK (Adenosine monophosphate–activated protein kinase)

Beyond the preview

Go deeper on ginsenoside Rg2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside Rg2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call